Blood pressure management in acute stroke: Does the scandinavian candesartan acute stroke trial (SCAST) resolve all of the unanswered questions?

Stroke

Volumn 42, Issue 10, 2011, Pages 2995-2998

  Fischer, Urs ^a   Rothwell, Peter M ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

acute stroke; hypertension; therapy

Indexed keywords

CANDESARTAN HEXETIL; PLACEBO;

ACUTE DISEASE; ACUTE ISCHEMIC STROKE; ACUTE STROKE; BLOOD CLOT LYSIS; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFECT; HEMATOMA; HUMAN; HYPERTENSION; NOTE; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; POSTSTROKE HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SCANDINAVIA; STROKE; STROKE PATIENT; SURVIVOR; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; STROKE; TETRAZOLES;

EID: 80053338962     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.619346     Document Type: Note

References (36)

1. Sandset EC, Bath PMW, Boysen G, Jatuzis D, Korv J, Lüders S, et al; on behalf of the SCAST Study Group. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377:741-750.
2. Wallace JD, Levy LL. Blood pressure after stroke. JAMA. 1981;246: 2177-2180. (Pubitemid 11030559)
3. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke. 1986;17:861-864. (Pubitemid 16000718)
4. Toyoda K, Okada Y, Fujimoto S, Hagiwara N, Nakachi K, Kitazono T, et al. Blood pressure changes during the initial week after different subtypes of ischemic stroke. Stroke. 2006;37:2637-2639. (Pubitemid 44454691)
5. Olsen TS, Larsen B, Herning M, Skriver EB, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischaemic penumbra in patients with acute stroke. Stroke. 1983;14: 332-342.
6. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118:176-187.
7. Olsson T, Marklund N, Gustafson Y, Nasman B. Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke. Stroke. 1992;23:1573-1576.
8. Myers MG, Norris JW, Hachinski VC, Sole MJ. Plasma norepinephrine in stroke. Stroke. 1981;12:200-203.
9. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M, et al. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci. 2007;252:29-35. (Pubitemid 44909185)
10. Carlberg B, Asplund K, Hägg E. Factors influencing admission blood pressure levels in patients with acute stroke. Stroke. 1991;22:527-530.
11. Carlberg B, Asplund K, Hägg E. High blood pressure in acute stroke. Is it white coat hypertension? J Intern Med. 1990;228:291-292. (Pubitemid 20330735)
12. Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM, et al. Prevalence of elevated blood pressure in 563 704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32-38. (Pubitemid 44869006)
13. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33: 1315-1320. (Pubitemid 34517053)
14. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004; 43:18-24. (Pubitemid 38031905)
15. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632-1644.
16. Tikhonoff V, Zhang H, Richart T, Staessen JA. Blood pressure as a prognostic factor after acute stroke. Lancet Neurol. 2009;8:938-948.
17. Greegange C, Bath PMW. Interventions for deliberately lowering blood pressure in acute stroke. Cochrane Database Syst Rev. 2008;4: CD000039.
18. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
19. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1771.
20. Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, et al; on behalf of the ACCESS Study Group. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Acute Stroke Survivors. Stroke. 2003;34:1699-1703. (Pubitemid 36842630)
21. Hankey GJ. Lowering blood pressure in acute stroke: the SCAST trial. Lancet. 2011;377:696-698.
22. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al; for the INTERACT Investigators. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391-399.
23. Delcourt C, Huang Y, Wang J, Heeley E, Lindley R, Stapf C, et al; INTERACT2 Investigators. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke. 2010;5:110-116.
24. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358:1033-1041.
25. Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Jagger C, James MA, et al; on behalf of the COSACS Investigators. Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010;9:767-775.
26. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, et al. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8:48-56.
27. Fischer U, Bull LE, Silver LM, Mehta Z, Rothwell PM. Acute blood pressure after TIA and stroke in relation to pathological subtype, severity, and premorbid measurements: population based study [Abstract]. Cerebrovasc Dis. 2011;31(suppl 2):73.
28. Rothwell PM. Limitations of the usual blood pressure hypothesis and the importance of variability, instability and episodic hypertension. Lancet. 2010;375:938-948.
29. Rothwell PM, Howard SC, Dolan E, O'Brian E, Dobson JE, Dahlöf B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
30. Rothwell PM, Howard SC, Dolan E, O'Brian E, Dobson JE, Dahlöf B, et al. Effects of beta-blockers and calcium channel blockers on withinindividual variability in blood and risk of stroke. Lancet Neurol. 2010;9: 469-480.
31. Lavallée PC, Meseguer E, Abboud H, Cabrejo L, Simon O, Mazighi M, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007;6:953-960. (Pubitemid 47570023)
32. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, et al; on behalf of the Early use of Existing Preventive Strategies for Stroke (EXPRESS) Study. Major reduction in risk of early recurrent stroke by urgent treatment of TIA and minor stroke: EXPRESS Study. Lancet 2007;370:1432-1442.
33. Webb AJS, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive drug class on inter-individual variation in blood pressure: a systematic review and meta-analysis. Lancet. 2010;375:906-915.
34. Rha JH, Saver JL. The impact of recanalisation on ischaemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973. (Pubitemid 46568460)
35. Martin-Schild S, Hallevi H, Albright KC, Khaja AM, Barreto AD, Gonzales NR, et al. Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischaemic stroke. Arch Neurol. 2008;65:1174-1178.
36. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke. 2006;1:245-249.